QLT Prostate Cancer Treatment Wins FDA OK QLT Inc. (QLT.TO: Quote, Profile, Research) (QLTI.O: Quote, Profile, Research) said on Wednesday it won US regulatory approval for the six-month formulation of its prostate cancer treatment, Eligard.